|
Volumn 31, Issue 1, 2010, Pages 38-40
|
Vaccines in immunocompromised patients
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CD4 ANTIGEN;
CHICKENPOX VACCINE;
DIPHTHERIA TETANUS VACCINE;
HAEMOPHILUS INFLUENZAE TYPE B VACCINE;
HEPATITIS A VACCINE;
HEPATITIS B VACCINE;
IMMUNOGLOBULIN;
INACTIVATED VACCINE;
INFLUENZA VACCINE;
LIVE VACCINE;
MEASLES MUMPS RUBELLA VACCINE;
NEUTRALIZING ANTIBODY;
PNEUMOCOCCUS VACCINE;
PREDNISONE;
ANTIBODY PRODUCTION;
ANTIBODY RESPONSE;
ASPLENIA;
B LYMPHOCYTE;
BACTERIAL VIRULENCE;
CD4 LYMPHOCYTE COUNT;
GRAFT RECIPIENT;
HAEMOPHILUS INFECTION;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HEPATITIS A;
HEPATITIS B;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNE RESPONSE;
IMMUNOCOMPETENCE;
IMMUNOCOMPROMISED PATIENT;
IMMUNOGLOBULIN A DEFICIENCY;
IMMUNOPROPHYLAXIS;
INFECTION PREVENTION;
INFECTION RISK;
INFLUENZA;
INFLUENZA VACCINATION;
LIVER TRANSPLANTATION;
MORTALITY;
NOTE;
ORGAN DONOR;
PASSIVE IMMUNIZATION;
PNEUMOCOCCAL INFECTION;
REVACCINATION;
STREPTOCOCCUS PNEUMONIA;
T LYMPHOCYTE;
THERAPY DELAY;
TREATMENT CONTRAINDICATION;
VACCINE FAILURE;
VIREMIA;
CHILD;
CHILD, PRESCHOOL;
HUMANS;
IMMUNOCOMPROMISED HOST;
INFANT;
VACCINATION;
|
EID: 76149132019
PISSN: 01919601
EISSN: 15263347
Source Type: Journal
DOI: 10.1542/pir.31-1-38 Document Type: Note |
Times cited : (13)
|
References (0)
|